Overview Of Review (OoR) on PSILOCYBIN in Psychiatric Disorders
August 4, 2024 Pierfelice Cutrufelli, Antonio Di Francesco, Alessandro Rodolico et al.
This protocol describes an upcoming overview of reviews that will analyze existing systematic reviews and meta-analyses of randomized clinical trials on psilocybin therapy. The goal is to evaluate the therapeutic effects, safety profiles, and adverse effects of psilocybin across various psychiatric conditions diagnosed according to ICD-10 or DSM-5-TR criteria. The study will compare psilocybin therapy against placebo, no treatment, or standard drug therapies. The authors note the need to consolidate scattered evidence from the growing body of psilocybin research, which could inform future clinical applications and policy.